Oncothyreon Inc. (NASD:ONTY) was a big mover last session, as the company saw its shares rally 9% on the day. This rise can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock has risen 20.5% since Dec 27.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Oncothyreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare industry Actelion Ltd. (OTC:ALIOF), Gentium S.p.A (NASD:GENT) and Affymetrix Inc. (NASD:AFFX). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ONCOTHYREON (ONTY): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading